Business Wire

CA-ZYNGA

4.11.2021 14:02:10 CET | Business Wire | Press release

Share
Zynga Launches New FarmVille 3 Game Worldwide

Today, Zynga Inc. (Nasdaq: ZNGA), a global leader in interactive entertainment, announced the worldwide launch of FarmVille 3 , the exciting new edition of its iconic FarmVille franchise. The agriculture-simulation social game is now officially available to download on iOS and Android devices worldwide, as well as on the Mac M1.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211104005004/en/

Twelve years – and over 700 million downloads – after the original FarmVille was introduced to the world in 2009, FarmVille 3 is bringing to life a new beautifully crafted world filled with a rich cast of fully animated characters and interactive animals.

Returning to the franchise is the beloved guide Marie, who will welcome back the FarmVille community and greet new players as they build their homesteads and complete challenges. She will be joined by a fresh cast of farmhands with diverse backgrounds and skills who will assist players with new elements in the game, including new customizable farms and animal husbandry.

As players escape into this new world, they can adopt, nurture and raise baby animals from more than 150 breeds – and be rewarded with farm goods, like wool and butter, for their parenting efforts.

FarmVille 3 immerses players in a visually stunning new FarmVille experience infused with the sense of adventure, social connection and farming spirit that hundreds of millions of fans have come to love,” said Bernard Kim, President of Publishing at Zynga. “We warmly invite a new generation of players to meet the delightful new FarmVille characters and lovable animals who thrive in a gorgeous countryside filled with heart and humor.”

Click to watch

New Game Features

  • Variety of animals – Collect, breed and nurture more than 150 breeds of animals, ranging from the mainstay chickens and cows to the exotic tigers and fluffy alpacas
  • Diverse farmhands – Meet 30 characters with handy skills – such as baking, fishing, lumberjacking and crafting – that will assist you on your farm-building journey
  • A living, breathing world – Control weather patterns with dynamic in-game mechanics to speed up your crop growth, catch more fish or earn more coins
  • Customize everything – Dress your farmhands in seasonal outfits such as a pumpkin costume for Halloween or add a personal touch to your farm, animal house or vehicle by picking from a plethora of themed design options such as modern or Victorian decor
  • Neighborly social gameplay features – Form your own “co-op” to exchange goods with other players and cooperate to win events and unique decorations

Starting today, players who download the game within the next two weeks will receive a special starter kit with interactive features to help customize their farms, such as decorative elements and the ‘Early Bird’ profile picture.

FarmVille 3 is the latest addition to the FarmVille series, which includes FarmVille 2: Country Escape and FarmVille 2: Tropic Escape .

To view the supporting still and video assets for FarmVille 3 , please click here .

FarmVille 3 is available now for iOS, Android and Mac M1 as a free download.

For more information visit:
www.FarmVille3.com
Facebook
Instagram
Twitter

About Zynga Inc.

Zynga is a global leader in interactive entertainment with a mission to connect the world through games. With massive global reach in more than 175 countries and regions, Zynga has a diverse portfolio of popular game franchises that have been downloaded more than four billion times on mobile including CSR Racing ™, Empires & Puzzles ™, Golf Rival, Hair Challenge, Harry Potter: Puzzles & Spells, High Heels!, Merge Dragons! ™, Merge Magic! ™, Queen Bee ™, Toon Blast ™, Toy Blast ™, Words With Friends ™ and Zynga Poker ™. With Chartboost, a leading mobile advertising and monetization platform, Zynga is an industry-leading next-generation platform with the ability to optimize programmatic advertising and yields at scale. Founded in 2007, Zynga is headquartered in California with locations in North America, Europe and Asia. For more information, visit www.zynga.com or follow Zynga on Twitter , Instagram , Facebook or the Zynga blog .

About FarmVille

Launched on Facebook in 2009, FarmVille spawned a social gaming franchise that has drawn over 700 million installs worldwide across Facebook, web and mobile platforms. Offering players the ability to grow virtual crops and build digital farms together in real-time, FarmVille has entertained its fans in FarmVille 2 , FarmVille 2: Country Escape and FarmVille 2: Tropic Escape . FarmVille 3, a game developed by Zynga Helsinki, aims to reinvent the classic farm building genre and showcase the modern mechanics of mobile gaming.

FORWARD-LOOKING STATEMENTS

This message contains forward-looking statements relating to future game events and features. Forward-looking statements often include words such as “will,” “expect,” “plan,” “intend,” and statements in the future tense are generally forward-looking. The achievement or success of the matters covered by such forward-looking statements involves significant risks, uncertainties and assumptions. Undue reliance should not be placed on such forward-looking statements, which are based on information available to us on the date hereof. We assume no obligation to update such statements. More information about these risks, uncertainties and assumptions is or will be described in greater detail in our public filings with the Securities and Exchange Commission (the “SEC”), copies of which may be obtained by visiting our Investor Relations website at http://investor.zynga.com or the SEC’s web site at www.sec.gov .

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Industrial Decarbonization: Calderion, WenCo and Terravent Invest in Graforce to Scale Plasma Pyrolysis Globally25.2.2026 08:07:00 CET | Press release

The investor consortium comprising the Paris-based Next Generation Fuels Industrial & Technological fund Calderion (Audacia), alongside infrastructure developer Terravent and WenCo Family Office, announces the closing of a strategic double-digit million-euro financing round for Berlin-based Graforce GmbH. The investment is dedicated to the industrial scale-up of Graforce’s proprietary plasma pyrolysis technology, addressing the growing global demand for cost-efficient low-carbon hydrogen, syngas, and carbon removal solutions that are compatible with existing industrial infrastructures. Disruptive alternative to conventional processes Graforce’s technology aims at replacing CO₂-intensive legacy routes such as steam reforming and classical gasification. By applying plasma to methane, biogas, flare gas, and landfill gas, the process converts these streams into their valuable molecular components instead of emitting them. The result is a high-efficiency production of clean hydrogen and syn

Mevion Medical Systems Announces CE Marking of the MEVION S250-FIT™ Proton Therapy System, Expanding Global Access to Compact Proton Therapy25.2.2026 08:00:00 CET | Press release

CE Marking enables marketing and clinical use of the world’s first and only LINAC vault-ready proton therapy system across the European Union Mevion Medical Systems, the global leader in compact proton therapy, today announced that the MEVION S250-FIT Proton Therapy System has successfully completed the conformity assessment process and has received CE Marking under Regulation (EU) 2017/745 (EU MDR). This regulatory milestone enables the marketing, sale, and clinical use of the MEVION S250-FIT system throughout the European Union, building on the system’s existing U.S. FDA 510(k) clearance granted in September 2025. The MEVION S250-FIT is the first and only proton therapy system designed to fit into a standard radiation therapy vault. By enabling cancer centers to use their existing infrastructure, the MEVION S250-FIT dramatically reduces the cost, complexity, and timeline traditionally associated with proton therapy adoption. This opens a new pathway for hospitals and cancer centers a

Bureau Veritas:Sector-Leading Organic Revenue Growth of 6.5% in FY 202525.2.2026 07:30:00 CET | Press release

Strong margin improvement to 16.3% in FY 2025Positive growth outlook with continued margin expansion in 2026New EUR 200 million share buyback Bureau Veritas (BOURSE:BVI): 2025 key figures1 › Full-year revenue of EUR 6,466.4 million, up 6.5% organically (with 6.3% organic growth in Q4). At constant currency, the growth was up 7.3% year-on-year and up 3.6% on a reported basis, › Adjusted operating profit of EUR 1,052.9 million, up 5.7% versus EUR 996.2 million in FY 2024, representing an adjusted operating margin of 16.3%, up 32 basis points year-on-year and up 51 basis points at constant currency, › Operating profit of EUR 992.4 million, up 6.3% versus EUR 933.4 million in FY 2024, › Adjusted net profit of EUR 631.4 million, up 1.7% versus EUR 620.7 million in FY 2024, › Adjusted EPS stood at EUR 1.42 in 2025, with a 2.8% increase versus FY 2024 (EUR 1.38 per share) and up 9.2% at constant currency, › Attributable net profit of EUR 588.0 million, up 3.3% versus EUR 569.4 million in FY 2

Galderma Announces Triple Approval of New State-of-the-Art Restylane® Syringe in the EU, the U.S., and Canada, Reaffirming the Company’s Position at the Forefront of Injectable Aesthetics25.2.2026 07:00:00 CET | Press release

Regulatory authorities in the European Union (EU), the United States (U.S.), and Canada have approved a new state-of-the-art Restylane®syringe for use with a range of Restylane NASHA® lidocaine products in multiple indications in the face and in the hands1-3 Developed in collaboration with aesthetic practitioners, its innovative ergonomic design features a cushioned finger grip and thumb rest, to improve practitioner experience through better injection comfort and control, helping them deliver consistently premium results 4-7 The syringe’s carton packaging is the first in the industry to be made from 100% recyclable paper, and reaffirms Galderma’s commitment to sustainability and environmental responsibility 8 These approvals demonstrate Galderma’s strong heritage in Injectable Aesthetics, and its commitment to continuing to drive innovation in the field Galderma (SIX: GALD), today announced that regulatory authorities in the EU, the U.S., and Canada have approved a new state-of-the-ar

Azafaros Announces Publication of Preclinical Efficacy Data with Nizubaglustat in GM2 Gangliosidosis25.2.2026 07:00:00 CET | Press release

Preclinical proof-of-concept data in GM2 gangliosidosis demonstrated survival benefit, functional improvement and target engagementResults are published in the 7 January issue of the Journal of Inherited Metabolic DiseaseNizubaglustat is currently in Phase 3 registrational studies in GM1/GM2 gangliosidoses and Niemann-Pick type C disease (NPC) Azafaros, a company aiming to become a leader in lysosomal storage disorders (LSDs), focused on addressing especially neurological symptoms, today announced the publication of proof-of-concept preclinical data with its lead product, nizubaglustat, in GM2 gangliosidosis. The data, published in the 7 January issue of the Journal of Inherited Metabolic Disease in collaboration with the laboratory of Dr. Jagdeep Walia, Department of Pediatrics, Queen's University, Kingston, Canada, reinforce nizubaglustat’s potential to address unmet needs in rare LSDs and build on existing preclinical and clinical evidence. The preclinical study tested nizubaglustat

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye